DERMATOPATHOLOGY A VOLUME IN THE SERIES FOUNDATIONS IN DIAGNOSTIC PATHOLOGY WITH ACCESS CODE 3ED (HB 2025)

Part of the popular Foundations in Diagnostic Pathology Series, Dermatopathology, Third Edition, is a practical and affordable resource that is ideal for study and review as well as everyday clinical practice. With its highly templated format, clearly written text, and concise summary tables, this user-friendly reference helps both trainees and practicing pathologists accurately diagnose specimens, avoid pitfalls, and confidently sign out pathology reports on these often difficult and challenging cases.

• Covers a wide range of neoplastic and non-neoplastic disorders of the skin, with detailed discussions of metabolic, systemic, allergic, infectious, and inflammatory skin diseases and cutaneous neoplasms
• Offers a superb overview of key diagnoses in dermatopathology using a full-color format with integrated images that facilitate quick and easy retrieval of key facts
• Presents each pathologic entity's gross and microscopic features, prognostic and therapeutic considerations, ancillary studies, and differential diagnoses
• Includes up-to-date information on IHC staining techniques, molecular genetic techniques and diagnostic tests, ancillary tools, and dermatologic disorders in an easy-to-use format that’s perfect for exam prep and clinical application
• Features more than 1,000 color histopathologic and clinical images that demonstrate key features of pathologic lesions, helping readers recognize the huge variety of appearances that cutaneous biopsy samples can present
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Dr. Klaus Busam is a Professor of Pathology at Memorial Sloan Kettering Cancer Center and the Director of the combined Memorial Sloan Kettering/Cornell Dermatopathology Training Program. His training is from the Brigham & Women’s Hospital and Harvard Medical School combined program. His interests include the utilization of clinical, histological and molecular diagnostic methods to optimize diagnostic accuracy and best predict the behavior of melanocytic neoplasms. As a dermatopathologist, he is recognized as an international expert in the diagnosis of melanoma and is sent many second opinion cases both from within and outside of the United States. As a researcher he is focused on developing molecular based methods to improve the diagnosis and prognostication of melanocytic neoplasms. He has authored over 250 peer reviewed journal articles and numerous textbooks in dermatopathology.

Dr Pedram Gerami: Selected to Best Doctors in America 2019-2020, Dr Gerami is the director of the Skin Cancer Institute of Northwestern Medical Group (SCIN-Med) and the director of the Melanoma Program in the Skin Cancer Institute and the Melanoma clinic in the department of Dermatology. His clinical and research interests are primarily focused on melanoma skin cancer, atypical nevi and borderline melanocytic tumors such as Spitz tumors which may be difficult to classify. As a dermatologist, dermatopathologist and researcher focused in the care of patients with melanoma and atypical nevi, he has a unique perspective on the behavior of melanocytic neoplasms.